These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 17116401

  • 1. Chemically chaperoning the actions of insulin.
    Hansen PA, Waheed A, Corbett JA.
    Trends Endocrinol Metab; 2007; 18(1):1-3. PubMed ID: 17116401
    [Abstract] [Full Text] [Related]

  • 2. c-Jun N-terminal kinase pathways in diabetes.
    Yang R, Trevillyan JM.
    Int J Biochem Cell Biol; 2008; 40(12):2702-6. PubMed ID: 18678273
    [Abstract] [Full Text] [Related]

  • 3. Insulin signaling in health and disease.
    White MF.
    Science; 2003 Dec 05; 302(5651):1710-1. PubMed ID: 14657487
    [Abstract] [Full Text] [Related]

  • 4. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
    Srivastava AK, Mehdi MZ.
    Diabet Med; 2005 Jan 05; 22(1):2-13. PubMed ID: 15606684
    [Abstract] [Full Text] [Related]

  • 5. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA, Levens N.
    Curr Opin Investig Drugs; 2003 Oct 05; 4(10):1179-89. PubMed ID: 14649209
    [Abstract] [Full Text] [Related]

  • 6. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
    Ruan H, Pownall HJ.
    Curr Opin Investig Drugs; 2009 Apr 05; 10(4):346-52. PubMed ID: 19337955
    [Abstract] [Full Text] [Related]

  • 7. Molecular basis of insulin action.
    González-Sánchez JL, Serrano-Ríos M.
    Drug News Perspect; 2007 Oct 05; 20(8):527-31. PubMed ID: 18080040
    [Abstract] [Full Text] [Related]

  • 8. JNK: bridging the insulin signaling and inflammatory pathway.
    Liu G, Rondinone CM.
    Curr Opin Investig Drugs; 2005 Oct 05; 6(10):979-87. PubMed ID: 16259218
    [Abstract] [Full Text] [Related]

  • 9. Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation.
    Shi L, Zhang W, Zhou YY, Zhang YN, Li JY, Hu LH, Li J.
    Eur J Pharmacol; 2008 Apr 14; 584(1):21-9. PubMed ID: 18348886
    [Abstract] [Full Text] [Related]

  • 10. Newly approved and promising antidiabetic agents.
    Combettes M, Kargar C.
    Therapie; 2007 Apr 14; 62(4):293-310. PubMed ID: 17983555
    [Abstract] [Full Text] [Related]

  • 11. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J, Morales M, Caelles C.
    Diabetes; 2007 Jul 14; 56(7):1865-71. PubMed ID: 17416798
    [Abstract] [Full Text] [Related]

  • 12. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity].
    Bastarrachea RA, Montero JC, Saavedra-Gajardo I, Cerda-Flores R, Machado-Domínguez A, Comuzzie AG.
    Rev Med Chil; 2008 Jan 14; 136(1):107-17. PubMed ID: 18483661
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S, Fantus IG.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec 14; 21(4):621-40. PubMed ID: 18054739
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK.
    Ann Pharmacother; 2007 Jan 14; 41(1):51-60. PubMed ID: 17190843
    [Abstract] [Full Text] [Related]

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 14; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 18. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells.
    Chung SS, Kim M, Youn BS, Lee NS, Park JW, Lee IK, Lee YS, Kim JB, Cho YM, Lee HK, Park KS.
    Mol Cell Biol; 2009 Jan 14; 29(1):20-30. PubMed ID: 18936159
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.
    Corbould A.
    J Endocrinol; 2007 Mar 14; 192(3):585-94. PubMed ID: 17332526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.